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Bivalent promoter hypermethylation in
cancer is linked to the H327me3/H3K4me3
ratio in embryonic stem cells
Donnchadh S. Dunican* , Heidi K. Mjoseng, Leanne Duthie, Ilya M. Flyamer, Wendy A. Bickmore
and Richard R. Meehan*
Abstract
Background: Thousands of mammalian promoters are defined by co-enrichment of the histone tail modifications
H3K27me3 (repressive) and H3K4me3 (activating) and are thus termed bivalent. It was previously observed that
bivalent genes in human ES cells (hESC) are frequent targets for hypermethylation in human cancers, and depletion
of DNA methylation in mouse embryonic stem cells has a marked impact on H3K27me3 distribution at bivalent
promoters. However, only a fraction of bivalent genes in stem cells are targets of hypermethylation in cancer, and it
is currently unclear whether all bivalent promoters are equally sensitive to DNA hypomethylation and whether
H3K4me3 levels play a role in the interplay between DNA methylation and H3K27me3.
Results: We report the sub-classification of bivalent promoters into two groups—promoters with a high
H3K27me3:H3K4me3 (hiBiv) ratio or promoters with a low H3K27me3:H3K4me3 ratio (loBiv). HiBiv are enriched in
canonical Polycomb components, show a higher degree of local intrachromosomal contacts and are highly
sensitive to DNA hypomethylation in terms of H3K27me3 depletion from broad Polycomb domains. In contrast,
loBiv promoters are enriched in non-canonical Polycomb components, show lower intrachromosomal contacts and
are less sensitive to DNA hypomethylation at the same genomic resolution. Multiple systems reveal that hiBiv
promoters are more depleted of Polycomb complexes than loBiv promoters following a reduction in DNA
methylation, and we demonstrate that H3K27me3 re-accumulates at promoters when DNA methylation is restored.
In human cancer, we show that hiBiv promoters lose H3K27me3 and are more susceptible to DNA
hypermethylation than loBiv promoters.
Conclusion: We conclude that bivalency as a general term to describe mammalian promoters is an over-
simplification and our sub-classification has revealed novel insights into the interplay between the largely
antagonistic presence of DNA methylation and Polycomb systems at bivalent promoters. This approach redefines
molecular pathologies underlying disease in which global DNA methylation is aberrant or where Polycomb
mutations are present.
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Background
In the mammalian genome, DNA methylation at the 5′
position of cytosine (5meC) is required for normal em-
bryonic development [1]. In addition, DNA methylation
has been shown to play important roles in repetitive
element silencing, X-inactivation and genomic imprint-
ing [2–4]. Methylation is abundant at interspersed CpG
dinucleotides (CG) and is depleted from CpG island
(CGI) regions of high CG content which are often (~
70%) associated with gene promoters [5]. Additionally,
the presence of 5meC at promoter regions is generally
correlated with transcriptional inactivity [5].
Transcriptional repression and developmental gene
regulation are also controlled by the action of two major
classes of polycomb repressive complexes (PRCs). PRC2
mediates the methylation of lysine 27 on histone H3
(H3K27me3), via the SET-domain containing methyl-
transferase activity of EZH2, which is an epigenetic mark
associated with transcriptional silencing [6]. In parallel,
PRC1 ubiquitylates lysine 119 of histone H2A (uH2A),
utilising the E3 ligase activity of RING1B. PRC1 is asso-
ciated with chromatin compaction—although the pres-
ence of catalytically inactive RING1B is sufficient for the
compacted state [7]. Biochemical studies of PRC pro-
teins have revealed several complexes with distinct com-
positions and functions with the potential for significant
combinatorial diversity in each class of complexes. In
particular, canonical PRC1 complexes contain a Cbx
subunit and either PCGF2 or PCGF4 [8], while non-
canonical PRC1 variant complexes may contain other
components including RYBP or KDM2B instead of other
PCGF proteins [9]. Deposition of PRC histone marks
can arise by either PRC2-dependent recruitment of
PRC1, or vice versa [10, 11], and the combination of
PRC1 and PRC2 is thought to be essential for develop-
mental gene regulation and thus lineage specification.
Moreover, their importance is exemplified by the human
diseases involving PRC alterations: Weaver syndrome,
Ataxia telangiectasia and autism spectrum disorders
[12–14]. PRC2 (Ezh2−/−, Eed−/− or Suz12−/−) mouse
knockouts are lethal at postimplantation while PRC1
(Ring1b−/− or Kdm2b−/−) mice die subsequent to gastru-
lation [15–19].
An important aspect of epigenetic repression is that
5meC and H3K27me3 are rarely found coincident at the
same location in the genome [20]. For example, develop-
mentally regulated homeobox gene clusters are rich in
PRC marks, but relatively depleted of 5meC [21]. In con-
trast, interspersed repetitive sequences are enriched for
high levels of 5meC and relatively low levels of PRC
marks. Thus, it is possible that one role of 5meC is to
constrain PRC activity to high CG content regions of
mammalian genomes and inhibit its deposition at lower
CG content regions [22]. Alternatively, perhaps the role
of PRC is to prevent the spread of 5meC into gene pro-
moters which may have long-term negative effects on
transcriptional output.
Bivalent promoters are enriched for both repressive
PRC components and the activation-associated mark tri-
methylation of lysine 4 of histone H3 (H3K4me3) [23, 24].
Biochemical studies have shown that individual H3 his-
tones on given nucleosomes can be asymmetrically
marked with H3K27me3 and H3K4me3 [25]. The
Trithorax Group (TrX) member MLL2 (KMT2D; WBP7)
deposits H3K4me3 at promoters [26]. In the absence of
H3K27me3, H3K4me3 marked promoters are largely tran-
scriptionally active and contain high levels of RNA poly-
merase II (RPII) phosphorylated on serine 2 (S2P-CTD) of
the C-terminal heptapeptide-repeat domain (CTD) which
is associated with transcriptional elongation [27].
H3K27me3 and H3K4me3 co-occupied promoters are
termed ‘poised’, in that resolution of either mark is corre-
lated with transcriptional output: forced transcription can
remove H3K27me3 while loss of H3K4me3 reduces tran-
scription [28–31]. Importantly, bivalent promoters are
5meC depleted, in part due to the presence of H3K27me3
[32]. Interestingly, loss of MLL2 leads to accumulation of
H3K27me3 at previously bivalent promoters; therefore,
one role of MLL2-dependent H3K4me3 is to constrain
over-accumulation of H3K27me3 at bivalent promoters
which may affect the ‘poised’ equilibrium between these
opposing bivalent chromatin demarcations [33].
Loss of 5meC from repetitive DNA in Dnmt1−/−
knockout somatic cells leads to sequestration of Ezh2-
dependent H3K27me3 from PRC target genes to inter-
genic regions [21, 34]. Efforts have been made to investi-
gate whether this finding is restricted to differentiated
cell types [20, 35, 36]; however, these studies generally
utilised a broad definition of bivalent promoters as a sin-
gle class. Moreover, it is unknown if PRC compartmen-
talisation is affected in systems where 5meC is acutely
depleted and subsequently restored. An interesting asso-
ciation between bivalency and 5meC was the finding that
many bivalent genes in human ES cells (hESC) are fre-
quent targets for hypermethylation in human cancers
[37, 38]. Moreover, aberrant DNA hypermethylation is
observed at H3K27me3 enriched regions in microceph-
alic dwarfism patient-derived fibroblasts harbouring the
DNMT3AW330R/+ genotype within the PWWP domain
[39]. It remains incompletely understood whether all
broadly categorised bivalent genes respond to global hy-
pomethylation in pluripotent embryonic stem (ES) cells,
and if these represent primary targets for hypermethyla-
tion in transformed cancer cells.
Here, we characterise mESC lacking 5meC and show se-
verely disrupted H3K27me3 targeting. Clustering ap-
proaches reveal two distinct classes of bivalent gene
promoters which differ in hypomethylation response,
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expression and three-dimensional chromatin organisation.
We extend these findings to other aberrant 5meC systems
and show that PRC mis-targeting is reversible. Finally, we
demonstrate that a distinct group of hESC bivalent pro-
moters are preferentially targeted for promoter hyperme-
thylation in human cancer.
Results
Hypomethylated mESC show aberrant H3K27me3
distribution
To examine the impact of major depletion of 5meC on
PRC targeting, we re-analysed publicly available datasets
derived from triple knockout mESC lacking three DNA
methyltransferases—Dnmt1, Dnmt3a and Dnmt3b
(TKO) [40]. Following multi-omics re-analysis of
H3K27me3 ChIPseq and DNA methylation sequencing
data (whole-genome bisulfite sequencing (WGBS) and
reduced representation bisulfite sequencing (RRBS)), we
partitioned the mouse genome into non-overlapping 1
kb tiles [20, 41–43]. We observed that H3K27me3 was
severely disrupted in TKO cells: H3K27me3 is lost in 20,
211 tiles (overlapping 2943 bivalent promoters) and
gained in 34,685 tiles (overlapping 48 bivalent pro-
moters) (Fig. 1a). We related these alterations to paren-
tal wild-type mESC DNA methylation and, consistent
with other reports, we found that 5meC levels parti-
tioned into two states: lowly (< 10%) or highly methyl-
ated (> 80%) (Fig. 1b, right) [20, 44]. Using this
approach, we found that TKO-specific H3K27me3 loss
regions were poorly methylated in the parental wild-type
mES genome (Fig. 1b). In contrast, TKO-specific
H3K27me3 gain regions were highly methylated in par-
ental DNA—these reciprocal associations demonstrate,
similar to somatic cells lacking 5meC, that H3K27me3
and 5meC co-localisation was relatively rare and loss of
5meC was closely coupled to H3K27me3 redistribution
in mESC (Fig. 1b).
H3K27me3 deposition has a preference for GC-rich
unmethylated DNA, thought to be mediated in part by
the GC-binding CXXC domain of KDM2B which re-
cruits PRC2 through PRC1 [5, 15]. In addition, 5meC is
more abundant at lower GC content loci [29]; therefore,
we partitioned genomic 1 kb tiles into high and low GC
content. In addition to being poorly methylated, tiles
where TKO specifically loses H3K27me3 were more GC
rich (Fig. 1c). In contrast, besides association with high
5meC levels, TKO-specific H3K27me3 ‘gain’ tiles were
of lower GC content (Fig. 1c) [35]. For example, we
show a genome browser depiction of mouse Titin, which
had high wild-type 5meC and lacked H3K27me3 in
wild-type mESC. In TKO cells, Titin acquired de novo
H3K27me3 and was DNA hypomethylated (Fig. 1d). In
contrast, the Polycomb target gene Foxo3, lacked 5meC
and lost most detectable H3K27me3 in TKO cells
(Fig. 1d). Importantly, RNAseq data indicated that Poly-
comb core component expression (Ezh2, Eed and Suz12)
was unchanged in TKO cells (Fig. 1e) [32]. Taken to-
gether, these experiments showed that hypomethylated
mESC have a severely disrupted PRC distribution, which
is likely determined by the GC content and DNA methy-
lation status of the parental wild-type genome.
Identification of two distinct classes of bivalent gene
promoters
Given the redistribution of H3K27me3 in hypomethy-
lated mESC, we next asked if pre-existing wild-type
H3K27me3 levels had any bearing on its loss in TKO
cells. We partitioned wild-type H3K27me3 ChIPseq data
into quintiles and then assessed TKO H3K27me3 alter-
ations, demonstrating that the highest wild-type quintile
exhibited the most pronounced TKO H3K27me3 loss
(Fig. 2a). Conversely, lower wild-type H3K27me3 level
quintiles showed a moderate skew towards TKO
H3K27me3 gain (Fig. 2a). The majority of H3K27me3
enriched promoters are also marked by H3K4me3 in
mES [30], so we next focused our attention on pro-
moters classified as bivalent, H3K27me3-only or
H3K4me3-only.
First, we examined DNA methylation across bivalent,
H3K27me3-only and H3K4me3-only promoters and ob-
served that H3K4me3 presence was negatively associated
with DNA methylation at the centre of promoters and
positively associated remote from promoter centres
(Fig. 2b, Additional file 1: Figure S1). Bivalent marks
have been compared between wild-type and TKO cells
[36]. In contrast to promoter annotations used previ-
ously, we used a robust annotation of promoters based
on multiple (n = 8) wild-type mESC [45]. We found a
distinct loss of H3K27me3 from bivalent promoters in
TKO cells (Fig. 2c). Interestingly, H3K27me3-only re-
gions showed little change in TKO (see average profiles);
therefore, we focused on bivalent promoters. Notably,
H3K4me3 is unchanged in TKO cells (Fig. 2c). From our
analysis, ChIPseq signals for H3K27me3 and H3K4me3
over bivalent promoters existed as a ‘signal’ continuum
where the breadth of signal can vary from less than 0.5
kb to greater than 10 kb (Fig. 2c). Therefore, we used an
unsupervised machine learning k-means approach to ask
whether promoters classified as bivalent can be cate-
gorised further in terms of related chromatin-modifying
and chromatin-associated protein partners. After itera-
tive k-means clustering, to optimise the number of clus-
ters to implement, we utilised a k value of 2 for further
analysis (Additional file 2: Figure S2). We found two dis-
tinct bivalent promoter classes: hiBiv promoters had a
high H3K27me3:H3K4me3 ratio and higher occupancy
by PRC1/2 components; loBiv had a low H3K27me3:
H3K4me3 ratio and was relatively enriched for activating
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marks H3K4me3 and H2AZ (Fig. 2d, Additional file 3:
Figure S3, Additional file 4: Figure S4, Additional file 5:
Table S1). Given the heterogeneity of PRC1 com-
plexes, we analysed canonical- and non-canonical-
specific protein partners [46, 47]. We found that hiBiv
was enriched for canonical PRC component CBX2,
while loBiv is enriched with non-canonical PRC1.1
RYBP, emphasising the distinct chromatin configura-
tions between these bivalent promoter clusters
(Fig. 2e). Recently, it has been shown that Mll2
knockout mESC lose H3K4me3 and gain H3K27me3
at a subset of bivalent promoters [33]. Mining this
dataset showed low levels of MLL2 occupancy in
hiBiv and high MLL2 in loBiv, which was consistent
with the differential levels of H3K4me3 (Fig. 2e).
Finally, Fursova et al. reported a discrete set of mESC
loci which retain RING1B in the absence of PCGF1/
3/5/6 [48]. We classified these loci as either hiBiv or
loBiv and found an enrichment for hiBiv regions
which is consistent with the finding that these
retained loci are embedded in broad Polycomb
chromatin domains (Additional file 6: Figure S5) [48].
One prediction from the differing cluster chromatin
compositions is that loBiv genes may be more
compatible with transcription. Indeed, analysis of
wild-type and TKO RNAseq data showed that loBiv
bivalent genes were more highly expressed (albeit at
relatively low levels) (Fig. 2f). Interestingly,
Fig. 1 Hypomethylated mESC show aberrant H3K27me3 distribution. a Genome-wide volcano plot over 1-kb tiles showing redistribution of
H3K27me3 in TKO mESC (n = 1). b Histograms of RRBS DNA methylation in parental wild-type mESC (n = 1) for the indicated H3K27me3 1-kb tiles.
c Upper: scatter plots of parental wild-type mESC DNA methylation versus log2 fold changes in H3K27me3 for high and low CpG density 1-kb
tiles. Lower: scatter plots of differential DNA methylation versus log2 fold changes in H3K27me3 for high and low CpG density 1-kb tiles. d
Browser images of representative H3K27me3 gain (upper) and H3K27me3 (loss) regions, Titin and Foxo3 genes respectively. e RNAseq data in
wild-type and TKO ES cells (n = 3) showing no major changes in core Polycomb component transcripts Ezh2, Eed and Suz12. See Additional file
Table S3 for replicate metrics
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examination of expression changes in TKO mESC
showed that both bivalent clusters are upregulated
(median fold change), with hiBiv showing greater up-
regulation (Fig. 2f). We therefore asked whether this
was reflected in differences in RPII engagement and
CTD phosphorylation state. hiBiv was relatively
enriched for the paused form RPII-S5P, while loBiv is
relatively enriched for the elongating form RPII-S2p
and the active form RPII-S7P, which is consistent
with the transcription associated with these genes
(Fig. 2g). Given that hiBiv associated transcription is
lower than loBiv in mESC, we asked whether these
Fig. 2 Identification of two classes of bivalent promoters. a Boxplots showing H3K27me3 levels in parental wild-type ES quintiles of 1-kb tiled
regions (left) and log2-fold changes in H3K27me3 in the indicated quintiles (right). b Average plots of DNA methylation (WGBS) in wild-type
mESC (n = 1) across gene promoters defined as bivalent, HK27me3-only or H3K4me3-only. c Heatmap of H3K27me3 and H3K4me3 ChIPseq (n =
1) in bivalent, H3K27me3 only and H3K4me3 only regions defined in wild-type mESC. Bottom: average profiles of heatmap data. d k-means (k = 2)
clustering of histone modifications (n = 1) over bivalent regions in shown in 2c. Bottom: average profiles of heatmap data. Boxplot of mean
ChIPseq signal ratios for H3K27me3 and H3K4me3 over hiBiv and loBiv regions. Student’s t test used to compare two groups of ratios. e ChIPseq
heatmap of indicated chromatin-associated factors over hiBiv and loBiv (n = 1). Bottom: average profiles of heatmap data. f Left: wild-type mESC
expression (RNAseq, n = 3) of hiBiv and loBiv associated genes compared to all genes; right: log2-fold expression changes between TKO and wild-
type mESC (RNAseq, n = 3) of hiBiv, loBiv associated genes compared to all genes. g ChIPseq heatmap of indicated RPII forms (n = 1) over hiBiv
and loBiv. Bottom: average profiles of heatmap data. h Log2-fold expression changes between activin-induced differentiation and wild-type mESC
(RNAseq, n = 2) of hiBiv, loBiv associated genes compared to all genes. See Additional file Table S3 for replicate metrics
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genes are permissive to transcription during directed dif-
ferentiation. Using RNAseq data from undifferentiated
and activin-induced mESC, we found that both clusters
were upregulated in differentiated cells, with hiBiv show-
ing greater transcriptional output (Fig. 2h). Finally, we
tested whether stratification of bivalent genes using this
approach yielded functional differences in associated gene
functions. We found significantly enriched gene sets in-
volved in RPII transcription (hiBiv) and regulation of
multicellular organismal process (loBiv) (Additional file 7:
Figure S6). Taken together, we have identified two distinct
classes of bivalent promoters based on their chromatin
configuration, RPII-CTD modification state and permis-
siveness to transcriptional activation.
Loss of long-range interactions from hiBiv genes
Redistribution of H3K27me3 and 3D genome reorganisa-
tion in mESC cultured in 2i conditions (presence of MAPK
and GSK3 inhibitors, PD0325901 and CHIR99021 respect-
ively) can be blocked by constitutive Dnmt expression prior
to 2i conversion [49]. Reorganisation of H3K27me3 in
TKO mESC may be accompanied by alterations in chroma-
tin accessibility and compaction. Given the differential
chromatin configuration of hiBiv and loBiv, it is possible
that differences in higher-order chromatin structure exist
between the classes. First, analysis of wild-type DNA
methylation across hiBiv and loBiv showed low levels of
methylation centrally. In contrast, approximately 2 kb from
the regions centres we observed higher levels of DNA
methylation most noticeably at loBiv (Fig. 3a). Next, we
analysed DNaseI-seq (proxy for chromatin accessibility)
data from wild-type and TKO mESC. TKO-specific DNaseI
hypersensitive sites (DHS) are found at GC-poor regions
distal from transcription start sites (TSS) [50]. Consistent
with this, we found no clear changes in enzymatic sensitiv-
ity between wild-type and TKO mESC over a range of 10
kb in either cluster (Fig. 3b). Of note, hiBiv appeared to be
more accessible than loBiv in regions surrounding the peak
centre using this assay; however, this was not associated
with DNA hypomethylation (comparing J1 to TKO). In-
deed, higher accessibility of hiBiv remote from cluster cen-
tres is associated with lower levels of DNA methylation.
Fig. 3 HiBiv chromatin compaction is controlled by DNA methylation and PRC1. a Average plots of DNA methylation (WGBS, n = 1) in wild-type
mESC across gene promoters defined as hiBiv and loBiv. b DNaseI-seq (n = 2) heatmap over clusters hiBiv and loBiv. Bottom: average profiles of
heatmap data. c Averaged interaction ‘pileups’ between hiBiv and loBiv in Hi-C data (n = 2) from serum and 2i cultured cells. Value of the centre
pixel is shown in the bottom left corner of each heatmap. Pixel scale on right. d Averaged interaction ‘pileups’ between hiBiv and loBiv in Hi-C
data from wild-type (n = 4), RING1B I53A (n = 2) and RING1B KO (n = 2) cells. Value of the centre pixel is shown in the bottom left corner of each
heatmap. Pixel scale on right. See Additional file Table S3 for replicate metrics
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An alternative index of chromatin structure is biophys-
ical inter-region interactivity which can be measured
using chromosome conformation capture (3C) tech-
niques. We analysed Hi-C data (‘all versus all’ interaction
contacts) using pileup averages of intra-chromosomal in-
teractions in mESC and found many more contacts in
hiBiv than loBiv under serum conditions, which implied
lower levels of compaction in loBiv and was consistent
with the associated PRC1 components (Figs. 2d and 3c).
mESC cultured in 2i are thought to more closely repre-
sent cells of the inner cell mass and are globally DNA
hypomethylated compared to serum cultured cells [51].
Interestingly, we found reduced frequency of hiBiv long-
range contacts in transit between serum and 2i (Fig. 3c).
To test the role of PRC in chromatin conformation at
different clusters, we compared wild-type, E3 ligase null
Ring1b and Ring1b knockout mESC average pileups. We
found that average pileup contacts are dependent on the
presence of RING1B protein but not its E3 ligase activity
(Fig. 3d). Taken together, these findings suggested a
functional difference between hiBiv and loBiv promoters
based on higher order chromatin structure.
Dynamics of hiBiv and loBiv promoters in early
embryonic development
mESC are isolated and derived from the inner cell mass
(ICM) of early mouse blastocysts and are thought to re-
flect the pluripotent state of this developmental stage
[52]. Using the clustering sets defined from chromatin
marks in mESC (Fig. 2d), we mapped H3K27me3 and
H3K4me3 in oocytes and early cleavage stages of the
mouse zygote [23]. We found that these chromatin
marks were highly dynamic over this narrow window of
development (Fig. 4a, b). H3K27me3 was highly abun-
dant in mouse oocytes and this was dramatically reduced
post-fertilisation before recovery to higher levels in the
blastocyst ICM (Fig. 4a). Similar to the mESC signature,
ICM H3K27me3 was lower in loBiv than hiBiv (Fig. 4a).
H3K4me3 had a reciprocal pattern to H3K27me3: signal
was absent in oocytes followed by establishment at the
two-cell stage through to morula stages during which
H3K27me3 was very low (Fig. 4a, b). Consistent with the
idea that mESC reflect their tissue of origin, the ICM and
mESC patterns for both marks were globally highly com-
parable (Additional file 8: Figure S7). Of interest, was the
fact that conversion of mESC from serum to 2i conditions
yielded H3K27me3/H3K4me3 profiles more similar to the
ICM than mESC cultured in serum (Fig. 4a, b).
To relate the dynamic remodelling of bivalency in
early development to DNA methylation, we examined
WGBS data in oocytes and early embryonic stages (two-
cell, four-cell and ICM). We determined that DNA
methylation centred on the TSS of hiBiv regions was
very low at the stages analysed, in contrast to loBiv,
which was moderately methylated (Fig. 4c). In general,
important regulatory sequences remote from TSS,
termed CGI shores, had higher levels of methylation
which was depleted as embryogenesis proceeded (Fig. 4d)
[53]. Importantly, the relationship between promoter
class (hiBiv or loBiv) and DNA methylation is consistent
between early embryos and ES cells (Figs. 3a and 4a–d).
Interestingly, repetitive DNA methylation which was
high in female germ cells is reduced in two-cell and
four-cell stages followed by a dramatic reduction in the
ICM (Fig. 4e). These observations were consistent with
the global DNA hypomethylation during early mouse em-
bryogenesis [54]. Therefore, global reduction in DNA
methylation between female germ cells and early embry-
onic cleavages correlated with remodelling of H3K27me3
at promoters. Notably, this relationship was not observed
in the ICM as here DNA methylation was relatively low
while H3K27me3 recovered (Fig. 4a, e).
H3K27me3 redistribution is generally associated with
DNA hypomethylation and is reversible
While TKO mESC are a widely utilised mouse model of
DNA hypomethylation, we next tested other DNA hypo-
methylation systems based on different mutations and
culture conditions for appropriate H3K27me3 localisa-
tion. Using hiBiv and loBiv as the bivalent PRC reference
framework, we analysed ChIPseq datasets from mESC
cultured in 2i, Mbd3−/− KO cells and Lsh−/− neural pro-
genitor cells (NPC): ES 2i cells are globally hypomethy-
lated, Mbd3−/− ES and Lsh−/− NPC cells are depleted of
5meC at repetitive sequences (Fig. 5a) [51, 55]. In agree-
ment with our findings in TKO cells, all the hypomethy-
lated cell type conditions showed a pronounced
H3K27me3 depletion from both clusters, with a greater
effect on hiBiv regions (Fig. 5a).
Differentiated cell types can be reprogrammed to induced
pluripotent stem cells (iPSC) in the presence of specific
transcription factors—for example OCT4, SOX2, KLF4 and
C-MYC (OSKM) [47]. We leveraged publically available
datasets for H3K27me3 ChIPseq and WGBS from ‘Project
Grandiose’, where mouse embryonic fibroblasts (MEF)
were passed through two rounds of iPSC reprogramming
[51, 56]. Notably, we found that global methylation was re-
modelled, prominently at repetitive sequences midway
through the secondary reprogramming stage and was re-
established in the secondary induced pluripotent stem cell
(iPSC) population (Fig. 5b). Therefore, we reasoned that if
DNA methylation is dynamic during secondary reprogram-
ming, that H3K27me3 would also show temporal alter-
ations during these cellular transitions. Indeed, ChIPseq
from the equivalent reprogramming phases indicated that
promoter H3K27me3, particularly hiBiv, showed similar re-
programming dynamics to DNA methylation (Fig. 5b, c).
H3K27me3 localisation alterations could not be simply
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explained by changes in core Polycomb component expres-
sion or major changes in Dnmt expression between sec-
ondary MEF and midway through reprogramming (D8H,
day 8 iPSC in high doxycycline) (Fig. 5d).
We next decided to test whether the reversible nature
of H3K27me3/5meC can be recapitulated without germ-
line transmission and viral OSKM integration. In con-
trast to previous Dnmt complementation experiments in
DNA methylation mutant mESC [36], we utilised a sys-
tem where the maintenance methyltransferase Dnmt1 is
under the control of a TET-off regulator—presence of
doxycycline (Dox) leads to highly tuneable acute Dnmt1
downregulation followed by DNA hypomethylation
without Dnmt1 deletion [57]. We performed WGBS on
Dnmt1tet/tet mESC under the following conditions:
serum, serum plus Dox (7 days) and serum upon Dox
withdrawal (7 days). We examined 5meC at repetitive se-
quences and found robust reduction of 5meC in the
presence of Dox, which largely recovered after Dox with-
drawal (Fig. 5e). In addition, although hiBiv and loBiv
TSS had low 5meC levels in serum, the dynamics of re-
petitive DNA 5meC changes were similar at TSS—thus,
in this system, DNA methylation was largely reversible
independent of germline transmission and OSKM inte-
gration (Fig. 5e). Given our findings in MEF to iPSC re-
programming, we performed H3K27me3 ChIPseq at the
Fig. 4 Developmental dynamics of Polycomb and DNA methylation. a, b ChIPseq heatmap profiles for H3K27me3 (red) and H3K4me3 (green) in
oocyte, early mouse cleavage developmental stages and mESC (serum and 2i conditions). Bottom: average profiles of heatmap data. H3K27me3
replicates: oocyte (n = 3), 2 cell (n = 3), 4 cell (n = 3), 8 cell (n = 3), morula (n = 3), ICM (n = 2), ESC serum [4] and ESC-2i (n = 1). H3K4me3 replicates:
oocyte (n = 4), 2 cell (n = 3), 4 cell (n = 3), 8 cell (n = 3), morula (n = 3), ICM (n = 2), ESC serum [2] and ESC-2i (n = 1). c Violin plots of WGBS DNA
methylation levels, adjacent to TSS, in the indicated samples for hiBiv and loBiv. d Violin plots of WGBS DNA methylation levels, at CGI shores, in
the indicated samples for hiBiv and loBiv. e Violin plots of WGBS DNA methylation levels at repetitive sequences in the indicated samples for
hiBiv and loBiv. Replicates (c–e): oocyte (n = 6), 2 cell (n = 9), 4 cell (n = 9) and ICM (n = 5). See Additional file Table S3 for replicate metrics
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Fig. 5 (See legend on next page.)
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equivalent time points and found that DNA hypomethy-
lation was coincident with prominent H3K27me3 loss
from hiBiv (Fig. 5f). Importantly, we found that
H3K27me3 deposition was reversible in this system as
its levels recovered to untreated serum levels subsequent
to Dox withdrawal. Notably, H3K27me3 loss from bi-
valent promoters had no major impact on H3K4me3
(Fig. 5f).
hiBiv are targets for DNA hypermethylation in cancer
Employing a similar approach used to predict murine bi-
valent promoters, we generated a robust set of bivalent
promoters in hESC. Using H3K4me3 and H3K27me3
ChIPseq from hESC, we grouped bivalent promoters
into two k-means clusters and, similar to mouse, hiBiv
had a high H3K27me3:H3K4me3 ratio while loBiv had a
low ratio (Additional file 9: Figure S8; Additional file 10:
Table S2). As for mouse, stratification of human bivalent
promoters in this manner yielded differential enrichment
of gene ontologies (Additional file 11: Figure S9). Given
our finding that DNA hypomethylation is associated
with H3K27me3 redistribution in a variety of mouse sys-
tems, we tested whether this finding is conserved in can-
cer cell line models and solid tumours. Strikingly, we
observed a pronounced loss of H3K27me3 from hiBiv
when comparing human mammary epithelial cell
(HMEC) to breast cancer cell lines or normal colon to
HCT116 colorectal cancer cells (Fig. 6a, Additional file 12:
Figure S10). H3K27me3 depletion from loBiv was not as
pronounced, consistent with mouse data where we dem-
onstrated that bivalent promoters with the highest wild-
type H3K27me3 levels were most depleted of the mark
under DNA hypomethylation conditions (Fig. 2a,
Additional file 12: Figure S10). A hallmark of cancer is
frequent hypermethylation of CGI promoters of cell
cycle regulation genes and it has been noted that these
targets are often bivalent in pluripotent mESC [37, 38].
Therefore, we analysed WGBS from the equivalent cell
lines and tissues and determined that hiBiv regions were
more highly methylated in breast cancer cell lines than
HMEC and to a lesser degree in colonic tumour com-
pared to normal tissue (Fig. 6b). LoBiv promoters were
less hypermethylated in cancer cell lines relative to
HMEC and in colon tumour compared to normal co-
lonic tissue (Fig. 6b). Next, we compared hiBiv and loBiv
associated genes with frequently hypermethylated cancer
gene promoters and found ~ 2.5 fold greater enrichment
of hiBiv promoters within this set compared to loBiv
(Fig. 6c). Additionally, differential methylation analysis
also showed greater hypermethylation in hiBiv relative
to loBiv (Fig. 6d).
Previously, it was shown that frequently hypermethylated
genes are already repressed in originating pre-cancerous tis-
sues [58]; therefore, we analysed RNAseq data from breast
and colon samples. We found that genes associated with
hiBiv and loBiv promoters, which have depleted
H3K27me3 and higher 5meC, were not significantly altered
in expression (Fig. 6e). This implies that one transcriptional
repression mechanism (DNA methylation) may be com-
pensating for the loss of a distinct repressive mechanism
(Polycomb). To expand on these findings, we mined Pan-
Cancer Atlas Infinium 450K DNA methylation data parsed
for breast tissues and gastrointestinal tract. Mean CpG pro-
moter methylation was computed for controls and patients
and hierarchical clustering heatmaps indicate qualitative
differences in hypermethylation between hiBiv and loBiv
patients (Fig. 6f; Additional file 13: Figure S11;
Additional file 14: Figure S12). Indeed, analysis of unique
individual CpG methylation showed a greater skew towards
hypermethylation in hiBiv compared to loBiv (Fig. 6f). We
also report similar trends in gastrointestinal tumours
(Fig. 6f). Importantly, we found little evidence of DNA
hypermethylation at promoters that are characterised as
H3Kme3-only or H3K27me3-only, supporting the idea that
bivalent genes are more prone to DNA hypermethylation
and in particular hiBiv promoters (Additional file 15:
Figure S13; Additional file 16: Figure S14).
Global hypomethylation is a common feature of can-
cers and may explain, in part, depletion of H3K27me3
from cognate target sites [21, 33]. In addition to DNA
hypomethylation, abnormal Polycomb expression and/or
function has been described in many malignancies.
Moreover, investigation of the impact of Polycomb loss
on mESC DNA methylation has been limited to a re-
duced genomic fraction (4 kb over mouse TSS) [32].
Thus, we focused on cultured mESC lacking key factors
(See figure on previous page.)
Fig. 5 DNA methylation dependent Polycomb targeting is common and reversible. a Left: H3K27me3 ChIPseq heatmap profiles for hiBiv and
loBiv in the indicated cell types and associated mutants. Bottom: average profiles of heatmap data. Replicates: E14 serum/2i (n = 1), ES WT/Mbd3
−/− (n = 2) and NPC WT/Lsh−/− (n = 1). Right: 5meC liquid chromatography mass spectrometry (LC-MS) comparing wild-type and Lsh−/− NPC
(n = 3). b Repeat class DNA methylation (WGBS) boxplots during iPSC reprogramming. Replicates: 2oMEF (n = 8), D8H (n = 11), 2oIPS (n = 8). c
H3K27me3 ChIPseq (n = 1) heatmap profiles over hiBiv and loBiv during iPSC reprogramming. Bottom: average profiles of heatmap data. d
RNAseq expression barplots for Polycomb components (top) and DNA methylation components (bottom) during iPS cell reprogramming. 2oMEF:
secondary reprogrammed MEFs; D8H: OSKM transduced MEFs in high doxycycline after 8 days; 2oiPSC: secondary reprogrammed induced
pluripotent stem cells. e Histograms (Satellite, LTR & L1) and boxplots (TSS) of WGBS (n = 1) during DNA methylation manipulation by repression
and re-activation of Dnmt1 expression in mESC. f H3K27me3 ChIPseq (n = 1) heatmap profiles over hiBiv and loBiv during DNA methylation
manipulation. Bottom: average profiles of heatmap data. See Additional file Table S3 for replicate metrics
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involved in the maintenance of PRC-mediated repression
(KDM2B, EED or RING1B). Consistent with previous
findings in Kdm2b−/− mESC [15], where KDM2B is
enriched at the majority of wild-type CGIs, we detected
hypermethylation at both hiBiv and loBiv in 500-bp win-
dows across TSS of the associated genes (Fig. 6g).
Fig. 6 DNA Hypermethylation of hiBiv in cancer. a Normal and cancer H3K27me3 ChIPseq (n = 1) heatmap profiles. Bottom: average profiles of
heatmap data. b Violin plots of absolute DNA methylation (WGBS) levels genome-wide in the indicated samples for hiBiv and loBiv. Replicates:
HMEC (n = 10), HCC1954 (n = 15), MCF7 (n = 1), colon (n = 3), tumour (n = 3). c Venn diagram of genes frequently methylated in cancer and genes
associated with human hiBiv and loBiv. F. E = fold-enrichment over random gene selection. d Kernel density plots of differential methylation at
human hiBiv and loBiv. e RNAseq boxplots for normal and cancer samples in the indicated clusters. Replicates: HMEC (n = 3), HCC1954 (n = 4),
MCF7 (n = 3), colon (n = 18), tumour (n = 18). f Pan-Cancer Atlas Infinium 450K DNA methylation data derived from breast and gastrointestinal
tissues. Upper: mean gene promoter unclustered methylation heatmaps; lower: histogram distribution of promoter associated individual CpG
methylation and inset boxplots with Fisher’s exact test. Breast dataset: controls (n = 86), patients (n = 780); colon dataset: controls (n = 33), patients
(n = 291). g Violin plots of absolute DNA methylation (WGBS) levels, adjacent to TSS, in the indicated samples for hiBiv and loBiv. h Violin plots of
WGBS absolute DNA methylation levels, at CGI shores, in the indicated samples for hiBiv and loBiv. Replicates (g, h): WT-C57Bl/6 J (n = 1), Kdm2b
−/− (n = 1), WT-J1 (n = 1), Eed−/− (n = 1), Ring1b (n = 1) and DKO (n = 1). See Additional file Table S3 for replicate metrics
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Surprisingly, although KDM2B is involved in non-
canonical PRC1 repression and targeting to CGIs, we
found little evidence of hypermethylation in mESC lacking
the PRC1 core factor RING1B (Fig. 6g). Furthermore, we
observed little hypermethylation in mESC lacking the
PRC2 components EED and RING1B (or in a Ring1b−/−/
Eed−/− double knockout) at either cluster. CGI shores and
their methylation states can contribute to tissue-specific
expression patterns, are highly conserved in mouse and
are frequently hypermethylated in cancer in contrast to
core CGI sequences [53]. Thus, we extended our mESC
PRC knockout analysis to CGI shores 2 kb from TSS. Sur-
prisingly, unlike core TSS sequences, we detected hyper-
methylation of CGI shores in PRC mutant mESC specific
to hiBiv (Fig. 6h). In contrast, wild-type loBiv CGI shores
were already methylated and thus methylation increases in
PRC mouse knockouts were minimal. In summary, we
found that hiBiv-associated promoters are more suscep-
tible to hypermethylation in cancer (Fig. 7), and that un-
like deletion of non-canonical Kdm2b in mESC, deletion
of canonical PRC components was associated with CGI
shore hypermethylation.
Discussion
Here, combining systematic and comprehensive map-
ping of H3K27me3 and DNA methylation with chroma-
tin conformation and transcription, we report on
Polycomb reorganisation in states of DNA hypomethyla-
tion. We determined that H3K27me3 localisation is
widely dependent on DNA methylation and H3K4me3
levels. Accordingly, Polycomb occupancy and DNA
methylation interplay is determined by specific chroma-
tin configurations and these relationships are pervasive
in stem cells, mouse development and cancer.
hiBiv promoters (enriched in Polycomb components with
high degree of chromatin contacts) exhibit reduced contacts
in DNA hypomethylated states and Polycomb mutants.
Many of these are Homeobox genes that exhibit reduced
chromatin compaction by FISH under the same conditions
[49]. Thus, the developmental occurrence of bivalency and
its participation in the formation of higher-order chromatin
structures maybe linked with de novo methylation in early
development [23, 59, 60]. Relevant to this is our finding that
H3K4me3 is prominent during DNA demethylation in the
early mouse embryo. Such a scenario can be envisaged as
global demethylation triggering H3K27me3 redistribution,
which renders gene promoters permissive to H3K4me3 ac-
cumulation and subsequent initiation of zygotic gene activa-
tion (ZGA). Notably, during ZGA, H3K27me3 is depleted
from hiBiv and loBiv equally, while H3K4me3 accumulates
to higher levels at loBiv regions, in agreement with our ob-
servation that loBiv regions have a higher potential for a
positive transcriptional output.
A previous study demonstrated that complementation
of de novo methyltransferase activities in DKO
(Dnmt3a−/−, Dnmt3b−/−) hypomethylated mESC partially
restores a wild-type chromatin state in terms of
H3K27me3 localisation [36]. Global loss of DNA methy-
lation in our models (mESC models: 2i and Mbd3−/−;
OSKM reprogramming intermediates and Lsh−/−NPCs)
is accompanied by striking H3K27me3 depletion from tar-
get sites at highly H3K27me3 enriched hiBiv regions. Un-
like the DKO complementation rescue experiments, this
state is fully reversible with re-expression of DNMT1 or
reprogramming of differentiated cells to iPS cells, which is
likely to be a critical mechanism during phases of DNA
demethylation and remethylation in early zygote and germ
cells [61, 62]. A molecular explanation for the difference
between DKO ESC and models explored here is unclear.
DKO cells are null for Dnmt3a/Dnmt3b while our rever-
sion experiments retain all three DNA methyltransferases
and the fibroblast reprograming is transmitted through
the germline—thus providing a potential explanation but
further work may be informative.
Despite many advances, it is still unclear how de novo
DNA methylation at bivalent CGIs is targeted in cancer
[63]. The number of hESC bivalent chromatin CGIs do not
fully account for the variability of CGI hypermethylation
observed in breast and colon cancers. ESC hiBiv CGIs,
enriched in canonical PRC1 components and much re-
duced H3K4me3, that are preferentially hypermethylated in
cancer add clarity to this process. De novo DNA methyla-
tion is mediated by the histone modification state of its tar-
get sequences and is inhibited by the presence of H3K4me3
[64, 65]. Global DNA hypomethylation in cancer and sub-
sequent H3K27me3 hiBiv depletion may be sufficient for
aberrant DNMT3B activity to promote hypermethylation at
these regions. This is likely not the case for loBiv bivalent
CGI as higher levels of H3K4me3 will inhibit potential de
novo methyltransferase activity [66]. In a DNMT3B over-
expression model, low expression H3K27me3 enriched
CGIs were the prime target for hypermethylation while re-
gions enriched for H3K4me3 were protected from DNA
methylation gains [66]. A missense mutation
(Dnmt3aD329A) in the PWWP targeting domain of
DNMT3A can result in hypermethylation of CGI in mice
particularly at CGI promoters and gene bodies marked by
H3K27me3, representing an alternative hypermethylation
pathway which may be utilised in specific cancer contexts
such as acute myeloid leukaemia [67]. Interestingly a simi-
lar mutation identified in a patient with microcephalic
dwarfism (Dnmt3aW326R) results in CGI methylation in the
continued presence of H3K27me3 [39, 67].
We propose that in normal cells spurious de novo DNA
methylation at CGI is prevented by opposing DNA de-
methylation pathways (TET enzymes), PRC1/2 complexes
and H3K4me3. Indeed, there is a relative enrichment of
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5hmC bivalent promoters in normal cells that are prone to
de novo methylation in a mouse model of liver cancer [68].
Interestingly, loss of 5hmC is an early event in this model
and precedes the appearance of hypermethylated regions in
the end-point cancers. Thus, we can speculate that similar
to early mouse development, the order of events is loss of
5hmC protection at hiBiv CGI followed by global hypome-
thylation redirecting H3K27me3 away from these regions
enabling de novo methylation at regions with low levels of
H3K4me3. Additionally, our findings potentiate a role for a
lack of H3K4me3 in enabling de novo methylation at po-
tentially vulnerable hiBiv CGI. In the future, it may be use-
ful to investigate whether there is also a link between low-
level H3K4me3 and de novo DNA methylation at other
discrete sets of CGI in cancer.
An alternative model is direct interference with Polycomb
function, which also occurs in many cancers and may lead
to hypermethylation [69–71]. Our analysis of mESC Poly-
comb mutants supports a causal association: inactivation of
the PRC1.1 variant component Kdm2b leads to significant
Fig. 7 Model for cancer DNA hypermethylation. a Polycomb complexes target H3K27me3 to unmethylated CGI (green arrows) enriched for
variable levels of H3K4me3. H3K27me3 is occluded from methylated interspersed CpG (black bar), e.g. repetitive elements/satellite DNA. Such
normal Polycomb targets are transcriptionally silenced. b Ageing cells and cells undergoing the early events of transformation become globally
hypomethylated at repetitive sequences. Polycomb H3K27me3 is redirected (most pronounced from hiBiv loci) to the high burden of
unmethylated interspersed CpG. It is unclear during this phase if hiBiv promoters are expressed. c At later stages of cellular transformation and
tumours, unprotected CGI are targets for retained de novo DNA methyltransferase activities—which is more prominent at hiBiv loci
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hypermethylation of hiBiv CGI and shores whereas inacti-
vation of core PRC1/PRC2 components, RING1B and EED
respectively, leads to methylation of CGI shores at hiBiv re-
gions. The continued presence of KDM2B in these mutants
may protect core hiBiv CGI, and to a lesser degree loBiv
CGI, from de novo methylation.
Much interest has centred on hypermethylation of genes
in cancer, where such events may act as drivers of tumouri-
genesis—assuming susceptible genes are silenced and are
involved in key cellular processes including proliferation,
apoptosis, senescence, angiogenesis, adhesion and many
others [63]. We find little evidence of gene expression
changes in hypermethylated hiBiv/loBiv in transformed
cell/tissue types. Therefore, H3K27me3 depletion triggered
by global hypomethylation in cancer cells may be compen-
sated by focal de novo hypermethylation at H3K27me3-
vacated loci—a scenario in which presumably one repres-
sive mechanism replaces another to maintain silencing of
these tightly regulated lowly expressed genes whose expres-
sion may interfere with cancer phenotypes (Fig. 7) [63].
Conclusion
A key conclusion from our findings is that classification of
bivalent gene promoters requires diligent sub-classification
using machine learning approaches based on epigenetic
marks. We propose that bivalent promoters should not be
considered a ‘blanket’ term but rather that subclasses of
bivalency exist in the context of an occupancy continuum.
Our novel distinction reported here provides the framework
to identify fundamental mechanisms underlying defects in
DNA methylation and chromatin state. We and others have
previously shown that aberrant 5meC can dramatically im-
pact H3K27me3 distribution in somatic and pluripotent
mouse cells [21, 36]. Now, we report consistency in this
finding in other DNA hypomethylation systems in higher
eukaryotes. We foresee that the application of bivalent gene
sub-classification to disease metadata will reveal common
themes (analogous to our findings) and disease-specific
events perhaps relating to disease pathology (i.e. tumour
stage), tissue of origin and degree of DNA hypomethylation
or Polycomb mutation load. In summary, this study refines
our knowledge of the antagonistic interplay between DNA
methylation and Polycomb and the complexity underlying




All cell lines were cultured using standard procedures.
Wild-type mESC (J1) were adapted to feeder-free condi-
tions and grown on gelatin-coated culture plates in media
composed of 15% FCS, GMEM (Gibco), 1% pen-strep, 1%
non-essential amino acids, 1% sodium pyruvate, 1% glutam-
ine, 0.1mM beta-mercaptoethanol and 500U/mL ESGRO
LIF. NPCs were derived from ESCs and cultured as previ-
ously described [72]. mESC were split at high density 24 h
prior to differentiation, followed by dissociation and PBS
washes to remove any traces of differentiation-inhibitory
serum. Cells were then cultured in neurodifferentiation
media (1:1 mix of Neurobasal (Gibco) and DMEM/F-12
media (Gibco) with 0.5% Neuro-2 Supplement (Millipore),
0.5% B27 Supplement (Gibco), 0.2mM L-glutamine and
0.1mM β-mercaptoethanol) and plated onto 0.1% gelatin-
coated flasks at a density of 3 × 105 cells per 75-cm2 flask
area. Media was changed on day 2 of differentiation and
then daily thereafter. Neural progenitor cells (10 days) cul-
tures were enriched using two passes of Magnetic Activated
Cell Sorting (MACS) with the anti-PSA-NCAM antibody
Microbead kit (Miltenyi Biotec; #130-097-859; lot:
5161208294; RRID: AB_2752096). Fluorescence-activated
cell sorting (FACS) using anti-PSA-NCAM antibody was
employed to assess NPC purity post MACS. For
Dnmt1tet/tet mESC experiments (clone termed ‘Ch9’), cells
were cultured as previously described except ESGRO LIF
(Millipore) was used at 500 U/mL. For Dnmt1 depletion,
doxycycline was added to media daily for 7 days at a con-
centration of 2μg/mL. For recovery, doxycycline was with-
drawn for 7 days. Dnmt1tet/tet mESC cells were a gift from
Richard Chaillet [57].
ChIPseq
Native ChIPseq was performed as previously described
[21]. In brief, soluble chromatin was isolated from nuclei
using NBR buffer (85mM NaCl, 5.5% sucrose, 10mM Tris,
3mM MgCl2, 1.5mM CaCl2,0.2mM phenylmethylsulfonyl
fluoride, 1mM dithiothreitol) and micrococcal nuclease
(Worthington, Lakewood, NJ, USA) overnight at 4 °C. Clari-
fied soluble chromatin was isolated by centrifugation. Im-
munoprecipitation was carried out with antibodies specific
to H3K4me3 (#07473, Millipore; lot: 2019729; RRID: AB_
1977252) and H3K27me3 (#07449, Millipore; lot:
DAM1662421; RRID:AB_310624) followed by antibody-
optimised washes. Samples from native ChIP were purified
using affinity columns (Qiagen, USA), and ChIP was vali-
dated using positive and negative control region primer sets.
ChIP DNA was treated with RNaseA (Roche Diagnostics,
West Sussex, UK) at 37 °C for 1.5 h and with Proteinase K
addition at 55 °C for 1 h. ChIP DNA were purified using the
QIAquick PCR purification kit (Qiagen). Library DNA was
assessed using a Bioanalyzer and quantitated using a Qubit
instrument, and sent to Edinburgh Genomics (UK) for Illu-
mina library preparation and sequencing. Crosslinked ChIP
was performed for Kdm2b and uH2A (antibodies were a gift
from Robert Klose, Oxford) as previously described [10],
and barcoded libraries were prepared using NEBNext®
Ultra™ DNA Library Prep Kit for Illumina coupled with
NEBNext® Multiplex Oligos for Illumina (E7335/E7500,
NEB, USA).
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Directional RNA Library Prep Kit for Illumina (E7420,
NEB, USA) in conjunction with NEBNext® Multiplex
Oligos for Illumina (E7335/E7500, NEB, USA). Libraries
were assessed for amplification, size range and quantity
using the Bioanalyzer and Qubit. Adaptor barcoded li-
braries were sequenced using v4 chemistry paired-end
strand-specific 50 bp on an Illumina HiSeq 2500 instru-
ment (Illumina, USA) by Edinburgh Genomics (Univer-
sity of Edinburgh) or using a NextSeq 500 instrument by
the WTCRF (Edinburgh University).
Bisulfite sequencing and liquid chromatography mass
spectrometry (LC-MS)
Genomic DNA was isolated from cell lines using lysis buf-
fer SETN (0.2% SDS, 5mM EDTA pH8.0, 100mM Tris-
HCl pH 8.0 and 200mM NaCl) and purified by proteinase
K, RNase A/T1 treatment followed by phenol:chloroform
extraction into TE buffer. Aliquots of genomic DNA were
assessed for quality, and whole-genome bisulfite sequencing
libraries were prepared and sequenced using a NextSeq 500
instrument by the WTCRF (Edinburgh University).
For LC-MS, 1 μg of DNA was hydrolysed to single nu-
cleotides with 10 units DNA degradase enzyme (Zymo
Research) and 2.5 μl DNA degradase buffer (Zymo Re-
search) in a 25 μl reaction. Samples were mixed with
100 μl mass spectrometry-grade methanol and 60 μl
mass spectrometry-grade acetonitrile (Sigma), centri-
fuged at 10,000 rpm for 5min and the upper 30 μl of
supernatant was transferred to mass spectrometry glass
vials. Standards for unmodified cytosine, 5mC and
5hmC were ran alongside the samples for comparison.
Liquid chromatography samples were separated on a
SeQuant ZIC-pHILIC column using a Thermo UltiMate
3000 BioRS with a flow rate of 0.3 ml/min and a gradient
of 90% to 5% acetonitrile in 10 min. Eluting peptides
were analysed on a Thermo Q Exactive in negative
mode, scanning from 300 to 350 m/z at resolution 70 k.
AGC target was set to 3 × 106 and maximum ion time
500 ms. Data was analysed using the Xcaliber
programme to quantify the area under the peaks. Levels
of 5mC were taken as a percentage of total cytosines (i.e.
unmodified, methylated and hydroxymethylated).
Datasets
Next-generation sequencing datasets were obtained from
multiple public sources: NCBI (http://www.ncbi.nlm.nih.
gov/sra & http://www.ncbi.nlm.nih.gov/geo), EBI (http://
www.ebi.ac.uk/ena) and DDBJ (http://trace.ddbj.nig.ac.
jp/index_e.html). See Additional file 17 Table S3.
ChIPseq analysis and data display
ChIPseq data was downloaded from publically available
sources and produced in-house. In most cases, NGS data
was downloaded in the form of compressed fastq files.
Next, library quality was assessed using FastQC tools by
sampling 1 million reads and viewing base statistics, per
base sequence quality, sequence duplication levels and
adaptor contamination. In addition, Picard tools was
used with Java in Unix to assess library complexity. In
appropriate cases, reads were either 5′ or 3′ trimmed as
required to remove adaptors, barcodes, read-through
adaptors, read-through barcodes and low sequence qual-
ity ends (TrimGalore tool from FastQC suite. Extra set-
tings were: -q 30 –illumina/nextera --stringency 6).
Fastq raw data was mapped to the mouse genome
(mm10 build) or the human genome (hg38 build) using
bowtie v2.2.6: bowtie2 -p 4 -N 1 -t -L 28 --phred33-
quals. All mapped bam files were indexed for rapid ac-
cess using SAMtools bam indexing. For heatmap pro-
duction, deepTools was implemented. The first step
involves calculating genome coverage in mapped bowtie
bam output files: bamCoverage –b mapped.bam –bai
indexed.bai –normalizeUsingRPKM -p 4 -f 300 --ignore-
Duplicates --minMappingQuality 30 –o out.bigwig.
Next, a matrix of genome coverage is generated using
the coverage file sets of genomic coordinate regions of
interest in bed file format using computeMatrix: compu-
teMatrix reference-point --referencePoint center -R
regions.of.interest.bed -S out.bigwig(s) --outFileName
matrix.file --outFileNameData averages --outFileSorte-
dRegions regions.bed --beforeRegionStartLength 10,000
--afterRegionStartLength 10,000 --binSize 100 --sortRe-
gions no –missingDataAsZero. The final step in heat-
map production utilises plotHeatmap: plotHeatmap
--matrixFile matrix.file --outFileName heatmap.eps
--outFileNameData data_underlying_average_profile
--outFileSortedRegions regions.bed --outFileNameMatrix
data_underlying_matrix --sortRegions descend --sortUsing
mean --averageTypeSummaryPlot mean --missingDataCo-
lor 1 --colorMap afmhot_r --zMin 0.0 --zMax 50.0 --heat-
mapHeight 15.0 --heatmapWidth 7.5 --whatToShow “plot,
heatmap and colorbar”. Average profile plots were pro-
duced directly from the ‘averages’ output from compute-
Matrix using the R programming environment. The R
‘t.test’ function was used to assess statistical differences be-
tween average profiles. Volcano plots were used to illustrate
log2 transformed fold change in TKO/J1 cells for
H3K27me3 ChIPseq data. Non-overlapping windows of 1
kb were intersected with ChIPseq read coordinates BED-
Tools. For each window, log2 transformed (TKO/J1) read
depth and –log10 transformed (p value from Fisher’s exact
test) was computed and plotted using the generic ‘plot’
function in R.
Bisulfite sequencing and data display
Raw bisulfite sequencing fastq files were trimmed for base
call quality and adaptors using TrimGalore (v0.4.1).
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Bismark (v0.16.3) m-bias plots were produced to plots per-
mit removal of non-native end-repair cytosines, followed by
mapping using the following settings: bismark --bowtie2
genome-build (mm10/hg38) --multicore 3 -o output
--non_bs_mm − 1 trimmed_read_1–2 trimmed_read_2.
Methylation was inferred from bismark_methylation_ex-
tractor: bismark_methylation_extractor --gzip --report -o
output --multicore 3 --genome_folder genome-build
(mm10/hg38) --counts --zero_based --cytosine_report
--bedGraph --comprehensive bismark_output. Only cyto-
sines in the CpG context at a minimum depth of five reads
were considered for downstream analysis. BEDTools
(v2.25.0) was used to overlap CpG methylation data with
genomic features (i.e. promoters, CGI shores, repetitive ele-
ments) as defined by the UCSC table browser annotations
and repeatmasker. Boxplots and violin plots were produced
using the boxplot function and the vioplot package in R.
RNAseq analysis and data display
RNA sequencing fastq files were filtered for base call qual-
ity and trimming using FastQC (v0.11.4) and TrimGalore
(v0.4.1). Paired end mapping was performed using TopHat
(v2.1.1): tophat --no-coverage-search --library-type fr-
firststrand -G gene_model(mm10/hg38) -p 8 -o output
genome_build(mm10/hg38) fastq_1 fastq_2. Read counts
over annotated features (i.e. genes) were computed using
featureCounts (v1.6.0) as follows: featureCounts --verbose
-g gene_name -p -s 2 -a gene_model(mm10/hg38) -o out-
put tophat_output. featureCount data was imported into
R and converted to DESeq objects followed by computa-
tion of fold changes using a negative binomial test.
Correlation between WGBS and H3K27me3 occupancy
To produce the data shown in Fig. 1, processed WGBS and
ChIPseq data were read into R memory. Genome-wide ana-
lysis: for the 1 kb ‘all windows analysis’, all WGBS data were
considered and a histogram was produced in R to reflect the
bipartite division of methylation presence (histogram peak
signals at either very low methylation (left-hand side of
plots) or very high methylation (right-hand side of plots)).
Next, we considered ChIPseq 1-kb windows genome-wide
with odds ratio scores of > 3 or < 0.33, corresponding to
threefold H3K27me3 gain windows and threefold
H3K27me3 loss windows respectively in TKO cells. These
coordinates were intersected with the WGBS data using
BEDTools (v2.25.0) and filtered histograms were plotted.
Definition of bivalent promoters and k-means clustering
Mouse bivalent genes (n = 3660) were defined as previ-
ously reported [45], where multiple H3K27me3 and
H3K4me3 ChIPseq datasets derived from multiple mESC
lines were integrated. H3K27me3-only and H3K4me3-
only genes were defined in a similar fashion. An unsuper-
vised machine learning algorithm, k-means clustering, was
implemented on multiple chromatin-related ChIPseq
datasets in wild-type mESC using a range of integer values
for k. One approach to determine the number of clusters
is the ‘elbow method’. This involves calculating the sum of
squared errors (SSE) for each value of k, and plotting a
line chart of the SSE value for each value of k. A value of
k = 2 was adopted for cluster definition as values of k > 2
extended beyond the elbow point, i.e. increasing the value
of k > 2 has limited impact on the SSE. To define human
bivalent genes, we mapped various H3K27me3 and
H3K4me3 ChIPseq datasets from multiple wild-type hESC
lines. Next, we carried out k-means clustering (k = 2) for
these datasets using genomic coordinates defined for hu-
man bivalent promoters previously described [45].
Heatmap and average profiles
Heatmaps and average profiles were done using a series of
tools within the deepTools suite (v3.2.0). In brief, read
coverage tracks (bigwig format) were produced from read
alignment files (bam format) using bamCoverage (bam-
Coverage -b in.bam -o out.bigWig -of bigwig -bl black-
listed_genomic_regions --normalizeUsing RPKM –
ignoreDuplicates; matrices underlying heatmaps were gen-
erated using computeMatrix (computeMatrix reference-
point --referencePoint center -p 4 -S in.bigwig(s) -R re-
gions_of_interest.bed -a 3000 -b 3000 --outFileName out-
put --outFileSortedRegions output_regions); finally
heatmaps were plotted using plotHeatmap (plotHeatmap
-m in.gz -out output.png --yMin 0 --yMax 25 --dpi 400
--xAxisLabel “from_centre” --plotTitle ‘Title’ --plotFile-
Format png –samplesLabel “Sample ID list”).
DNaseI-seq and Hi-C
DNaseI-seq raw sequencing data was mapped in similar
fashion to ChIPseq with minor exceptions. DNase-seq
reads were trimmed for adaptors and trimmed to 50
base pairs in length and then mapped: bowtie -p 3 -q
--sam -v 3 -m 1 --best --strata genome_build(mm10) - >
output.sam. Unmapped reads were trimmed to 25 base
pairs remapped as before to rescue short fragments. All
reads were merged using SAMtools (v1.3) and peaks
were called with MACS2 (v2.1.1). Heatmaps were pro-
duced as for ChIPseq. Hi-C data was analysed and aver-
age pileups were plotted as described previously [73].
Enrichment of hypermethylated cancer genes
A panel of frequently hypermethylated genes in cancer
was publically available [58]. Clusters 1 and 2 associated
gene promoters were overlapped with this set and fold-
enrichments were computed compared to iterations of
randomly chosen clusters of comparable size from all
human genes.
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UCSC browser tracks
Browser tracks for ChIPseq or WGBS were generated by
uploading bigwig files into the IGV browser (v2.5.2). Re-
gions of interest were entered as coordinates and images
were exported. WGBS and ChIPseq tracks were overlaid
in figure production.
Division of quintiles to define association between wild-
type H3K27me3 occupancy and H3K27me3 sensitivity to
DNA hypomethylation
Approaches to generate windows of ChIPseq enrichment
genome-wide have been previously described. In brief, a
custom script was produced in R to divide a given genome
into 1-kb windows. Next, bowtie outputs were converted to
bed files using BEDTools (v2.25.0), noting mapping metrics
for downstream normalisation. Bed files and genomic win-
dows were overlapped using BEDTools (v2.25.0) followed
by joining wild-type and paired mutant data into a single
database. We next used custom scripts to compute (a) log-
transformed fold changes, (b) Fisher’s exact test for testing
the null of independence of the database contingency table
and (c) odds ratio scores in terms of wild-type and mutant
ChIPseq windows, accounting for variations in library read
depth. The ChIPseq database was split into quintiles based
on wild-type ChIPseq signal, and this split database was
used to plot log-transformed mutant/wild-type fold changes
within the separate quintiles.
General bioinformatics tools
SRA Toolkit was employed to extract fastq read files from
the Sequence Read Archive format files (.sra) in situations
where data was unavailable in compressed fastq format.
HOMER was utilised for many core bioinformatics opera-
tions including (but not limited to) preparing UCSC for-
mat bigWig (.bw) files for browser display and genomic
coordinate annotation. Notably, we prepared bigWig files
using UCSC tools / BEDTools and we utilised R / BED-
Tools to manually annotate genomic coordinates to valid-
ate our HOMER analyses. To avoid hosting compressed
data on internet accessible servers we employed the local
genome browser IGV and we used IGVTools to create
low memory requirement ChIPseq pileup files in bigWig
or tdf format. We utilised DAVID as a comparison for
enriched gene ontologies output from REViGO.
Gene ontology analysis
The Gorilla gene ontology (GO) tool was used to calcu-
late GO term enrichment in hiBiv and loBiv in both
mouse and human ESC. Gene lists were submitted to
the Gorilla GO server against backgrounds of all unique
RefSeq genes for mm10 and hg38; settings: mouse,
‘ontology’ = process, P value threshold = 10−4; human,
‘ontology’ = process, P value threshold = 10−6. Gorilla
outputs were output to REViGO. Next, the REViGO tool
was used to reduce closely related GO term redundancy
in the Gorilla outputs. REViGO settings: ‘allowed simi-
larity’ = tiny; ‘numbers associated with GO categories are
… ’ = p values; ‘database’ = whole UniProt; ‘semantic
similarity measure’ = SimRel. R was used to plot the
REViGO two-dimensional semantic scatterplots.
Illumina Infinium 450K data analysis
Publically available DNA methylation data and the per-
taining manifest was downloaded from https://gdc.can-
cer.gov/about-data/publications/pancanatlas followed by
parsing into normal and tumour in the Unix environ-
ment. Next, extracted data for gastrointestinal tract and
breast were intersected with human hiBiv and loBiv
using BEDTools. Clustered (hierarchical) mean DNA
methylation heatmaps were plotted using R (v3.6.0)
encompassing 4 kb over TSS. Histograms were prepared
from the same regions of the genome on an individual
CpG basis. Differences between normal and tumour
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Additional file 1: Figure S1. Negative correlation between H3K4me3-
only enriched regions and DNA methylation in mouse and human ESC.
(Left) Scatterplot showing relationship between H3K4me3 ChIPseq
readcounts and mean DNA methylation (WGBS) in 4 kb tiles overlapping
H3K4me3-only regions (as defined by Mantsoki et al. in mouse ESC).
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Linear regression line of best fit is overlayed in blue. Pearson r-squared
value is indicated top left. WGBS from WT mouse ESC was generated in-
house. (Right) Scatterplot showing relationship between H3K4me3 ChIP-
seq readcounts and mean DNA methylation (WGBS) in 4 kb tiles
overlapping H3K4me3-only regions (as defined by Mantsoki et al. in
human ESC). Linear regression line of best fit is overlayed in blue. Pearson
r-squared value is indicated top left. Human methylation data was from
GEO accession GSM2138820.
Additional file 2: Figure S2. Selection of k value for k-Means clustering.
(a) The principle behind k-Means clustering is to identify clusters such
that the total within-cluster sum of squares (WSS) is minimised. The sum
of all WSS relates to cluster compactness and ideally should be as low as
possible. Values of k are systematically tested until further increases in k
do not improve the total WSS – the ‘elbow method’. A plot is shown
where cluster number (underlying the ChIPseq data in Fig. 2d) is plotted
against total WSS with k = 2 chosen as optimal for this data. R packages
‘factoextra’ and ‘NBClust’ were implemented for this analysis. (b) To
validate the choice of k we used the alternative ‘average silhouette
method’ approach accounting for cluster quality and inter-cluster
distances, which ideally are high and distinct respectively, for robust
clustering of non-random data. A plot is shown where cluster number
(data underlying Fig. 2d) is plotted against average silhouette width with
k = 2 returned.
Additional file 3: Figure S3. Differential H3K27me3 to H3K4me3
ChIPseq ratios at different genomic resolutions. (a) In Fig. 2d we show
differential H3K27me3:H3K4me3 ChIPseq ratios over a genomic window
of 4 kb. To test whether this result was due to the differing breadth of
H3K27me3 and H3K4me3 ChIPseq peaks we repeated the analysis at 4 kb
including two greater resolutions: 0.2 and 1 kb. hiBiv and loBiv were
compared using Pearson’s correlation indicating statistically different
H3K27me3:H3K4me3 ChIPseq ratios independent of window size. (b) To
statistically test if H3K27me3 depletion is linked to transcription start site
proximity, we analysed H3K27me3 depletion at three different
resolutions. This showed that the greatest difference in H3K27me3
depletion is at the highest genomic distance (+/− 5 kb from peak centre)
by boxplot analysis of mean J1:TKO H3K27me3 (rpkm) ratio per locus and
non-equal variance two sample Student’s t-Test. Further, largest TKO
H3K27me3 alterations occur at the highest DNA methylation level
resolution (+/− 5 kb). Over shorter genomic ranges (0.2-1 kb) hiBiv and
loBiv differential sensitivity is skewed towards loBiv regions based on
median values at lower significance. This is likely due to the marked
reduction in Polycomb presence at hiBiv regions, which are relatively
dominated by H3K4me3 occupancy over these narrow windows.
Mapping of average DNA methylation over the three genomic
resolutions indicates that DNA methylation is most abundant over the
10 kb range, implying that DNA methylation is unlikely to play a
prominent role in determining Polycomb localisation at the 0.2 and 1 kb
ranges.
Additional file 4: Figure S4. Quintile chromatin configuration at
murine bivalent promoters. As an alternative to k-means clustering we
divided the data underlying Fig. 2d into H3K27me3:H3K4me3 quintiles
determined by the ChIPseq signal ratio. We found that this approach
reproduces hiBiv (Q5). As with k-means clustering, the Q5 quintile is
relatively enriched in PRC components (EZH2, RING1B and uH2A) and
depleted of activating marks (H3K4me3 & H2AZ). Q4,Q3,Q2,Q1 account
for the loBiv set of regions. KDM2B, which binds to the majority of CGI is
relatively uniform across the five quintiles.
Additional file 5: Table S1. This additional table contains mouse hiBiv
and loBiv genomic coordinates, strand and neighbouring gene.
Additional file 6: Figure S5. Overlap between uH2A-retaining loci,
mouse hiBiv and mouse loBiv. (a) Genomic region coordinates and
associated gene names (n = 315) that retain uH2A in mouse ES (mESC)
cells lacking PCGF1/3/5/6 were obtained from the Klose lab. Of these, we
found n = 253 overlapping our n = 3659 bivalent genes in mESC (left
panel). Specifically, the majority of these (~ 78%) are the hiBiv class, while
~ 22% are the loBiv class – thus regions that uH2A in quadruple PCGF
knockout mESC are enriched in the hiBiv class (right panel). (b) Heatmaps
for the indicated ChIPseq datasets were plotted without clustering for
the regions that retain uH2A in PCGF1/3/5/6 mESC annotated as hiBiv or
loBiv. Bottom: average profiles of heatmap data.
Additional file 7: Figure S6. Gene ontology analysis of mouse hiBiv
and loBiv associated genes. Gorilla and REViGO tools were coupled to
define and reduce redundancy for enriched gene ontology terms in
murine hiBiv and loBiv compared to all genes. Colour coding of the
scatterplots are related to the log10 of the enriched p-values estimated
by Gorilla. Area of circular plotted data is proportional to the number of
genes enriched in each GO term. Redundant GO terms are reduced
using the method of ‘semantic similarity’ measurement which is
analogous to hierarchical clustering methods. This involves generating
clusters of similar GO terms based on close p-values and whether one
term is a child node of the other term [76].
Additional file 8: Figure S7. Dynamics of bivalency during early
embryonic development. Related to Fig. 4a. A similar approach adopted
in Fig. 2d was used to compute H3K27me3:H3K4me3 ratio based on
mean RPKM values in hiBiv and loBiv loci. Reciprocal ratios of
H3K4me3:H3K27me3 were also computed. Upper panel: hiBiv, lower
panel: loBiv.
Additional file 9: Figure S8. Human ESC hiBiv and loBiv defined
regions. (a) Human H3K27me3 and H3K4me3 ChIPseq datasets derived
from H1 and H9 human ESCs described in Mantsoki et al. [45]. were
downloaded and mapped using bowtie2 [45]. Multiple mapped files
(bam files) from each histone modification were merged and indexed
using Samtools. Coverage files (bigWig) and coverage matrices were
computed with deepTools using the human bivalent regions described
in Mantsoki et al [45]. (b) Human H3K27me3 and H3K4me3 ChIPseq
datasets derived from H1 human ESCs were downloaded from ENCODE
(Bing Ren, UCSD) and mapped using bowtie2. Multiple mapped files
(bam files) from each histone modification were merged and indexed
using Samtools. Coverage files (bigWig) and coverage matrices were
computed with deepTools using the human bivalent regions described
in Mantsoki et al. [45].
Additional file 10: Table S2. This additional table contains: human
hiBiv and loBiv genomic coordinates, strand and neighbouring gene.
Additional file 11: Figure S9. Gene ontology analysis of human hiBiv
and loBiv associated genes. Gorilla and REViGO tools were coupled to
define and reduce redundancy for enriched gene ontology terms in
human hiBiv and loBiv compared to all genes. Colour coding of the
scatterplots are related to the log10 of the enriched p-values estimated
by Gorilla. Area of circular plotted data is proportional to the number of
genes enriched in each GO term. Redundant GO terms are reduced using
the method of ‘semantic similarity’ measurement which is analogous to
hierarchical clustering methods. This involves generating clusters of
similar GO terms based on close p-values and whether one term is a
child node of the other term [76].
Additional file 12: Figure S10. Quintile chromatin configuration at
human bivalent promoters. Left panel: As an alternative to k-means
clustering we divided the data underlying Fig. S8 into
H3K27me3:H3K4me3 quintiles determined by the ChIPseq signal ratio
which emphasises the difference between Q5 and Q4 to Q1 inclusive. Q5
is consistent with hiBiv and Q4 to Q1 account for loBiv. Right panel: we
performed a similar quintile division of the data underlying Fig. 6a. Q5
quintile (which is most related to hiBiv) shows most H3K27me3-sensitivity
to DNA hypomethylation comparing HMEC to HCC1954/MCF7 and colon
to HCT116. In contrast, Q4 to Q1 show an attenuated H3K27me3-
response to DNA hypomethylation.
Additional file 13: Figure S11. Reproduction of TCGA breast
methylation data from Fig. 6f including high density dendograms. Shown
are the breast analyses from Fig. 6f including dendograms which indicate
clustered loci (y-axis) and controls/patients (x-axis).
Additional file 14: Figure S12. Reproduction of TCGA colon
methylation data from Fig. 6f including high density dendograms. Shown
are the colon analyses from Fig. 6f including dendograms which indicate
clustered loci (y-axis) and controls/patients (x-axis).
Additional file 15: Figure S13. Absence of hypermethylation at
H4Kme3-only and H3K27me3-only promoters. To test if cancer-specific
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DNA hypermethylation was more associated with high ratio
H3K27me3:H3K4me3 loci (hiBiv) than singly marked promoters, we ana-
lysed promoters characterised by the enrichment of either K4me3-only or
H3K27me3-only in human ES cells. We repeated our approach detailed in
Fig. 6f and found little evidence of promoter hypermethylation in either
breast or colon tumours at these loci.
Additional file 16: Figure S14. hiBiv subclass of bivalent promoters is
most susceptible to hypermethylation in cancer. We analysed degree of
hypermethylation and hypomethylation (as defined by a 20% or greater
alteration in mean DNA methylation per locus) in hiBiv, loBiv, H3K27me3
only, H3K4me3 only and latent (neither H3K27me3 nor H3K4me3) loci (as
defined by their demarcation in human ES cells). We next computed the
percentage of loci within each promoter class altered. Promoters with
greatest cancer hypermethylation events occur in the hiBiv class (27% of
all colon hiBiv loci; 8% of all breast hiBiv loci) followed by the loBiv class
(13% of all colon hiBiv loci; 2% of all breast hiBiv loci). Interestingly,
H3K27 only and latent loci exhibited the highest degree of DNA
hypomethylation events.
Additional file 17: Table S3. This additional table contains datasets re-
analysed in this manuscript. File format.
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